Inspire Medical Systems, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
65.00
58.00
-19.00
-44.00
-41.00
-57.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-87.00
-37.00
-40.00
1.00
-6.00
-10.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
116.00
130.00
24.00
11.00
-20.00
-53.00
Cash Flow from Investing Activities
21.00
-113.00
-294.00
-19.00
29.00
86.00
Cash Flow from Financing Activities
-183.00
-52.00
13.00
235.00
14.00
134.00
Net Cash Inflow / Outflow
-45.00
-35.00
-256.00
227.00
23.00
167.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Inspire Medical Systems, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
65.697
-317.000000000338
382.00
120.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-87.381
18.0000000000192
-105.00
-585.45%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
116.976
283.000000000302
-167.00
-58.67%
Cash Flow from Investing Activities
21.446
-455.000000000485
476.00
104.71%
Cash Flow from Financing Activities
-183.449
225.00000000024
-408.00
-181.53%
Net Cash Inflow / Outflow
-45.337
81.0000000000864
-126.00
-155.97%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.31
28.0000000000299
-28.00
-101.11%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -10.19% vs 428.32% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
116.98
130.25
-10.19%






